|
DSGN Design Therapeutics Inc 1807120 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-17,636,000.00 |
| Balance Sheet |
|
Current Assets
|
$227,049,000.00 |
|
Assets
|
$230,442,000.00 |
|
Current Liabilities
|
$10,190,000.00 |
|
Liabilities
|
$12,388,000.00 |
|
Equity
|
$218,054,000.00 |
|
Shares Out
|
62441429.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-16,431,000.00 |
|
Investing Cash Flow
|
$-7,589,000.00 |
| Market Analysis |
Market Cap
|
$788,010,833.98 |
|
Price
|
$12.15 |
|
BVPS
|
3.49 |
|
PB
|
3.62 |
|
EPS
|
-0.29 |
|
FCF
|
$-16,431,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:23 |
|
| Apr |
May |
Jun |
| 2026-03-09 |
-0.27 |
2026-04-28 |
-0.29 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.34 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.30 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DSGN documents filed with the SEC.
DSGN Filings
Clear
